Startseite Escitalopram in disorder of laughter and crying with predominant laughter incontinence
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Escitalopram in disorder of laughter and crying with predominant laughter incontinence

  • Debadatta Mohapatra , Biswa Ranjan Mishra EMAIL logo , Rituparna Maiti und Sudipta Das
Veröffentlicht/Copyright: 17. Dezember 2016

Received: 2016-7-4
Accepted: 2016-9-11
Published Online: 2016-12-17
Published in Print: 2017-1-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. The effect of caffeine on energy balance
  4. Genotoxicity and Cytotoxicity
  5. The effect of aqueous leaf extract of Telfairia occidentalis (Cucurbitaceae) on gentamycin-induced renal damage
  6. Oxidative Stress
  7. Ashanti pepper (Piper guineense Schumach et Thonn) attenuates carbohydrate hydrolyzing, blood pressure regulating and cholinergic enzymes in experimental type 2 diabetes rat model
  8. Comparative studies on the effects of clinically used anticonvulsants on the oxidative stress biomarkers in pentylenetetrazole-induced kindling model of epileptogenesis in mice
  9. Methanol extract of Nymphaea lotus ameliorates carbon tetrachloride-induced chronic liver injury in rats via inhibition of oxidative stress
  10. Inflammation
  11. Anti-inflammatory, anti-diarrheal, thrombolytic and cytotoxic activities of an ornamental medicinal plant: Persicaria orientalis
  12. Comparative pre-emptive analgesic efficacy study of novel antiepileptic agents gabapentin, lamotrigine and topiramate in patients undergoing major surgeries at a tertiary care hospital: a randomized double blind clinical trial
  13. Phytotherapy
  14. The ameliorating effect of Centella asiatica ethanolic extract on albino rats treated with isoniazid
  15. In vitro antioxidant and anti-inflammatory activities of isolated compounds of ethanol extract from Sanchezia speciosa Leonard’s leaves
  16. Case Report
  17. Blepharospasm: an uncommon adverse effect caused by long-term administration of olanzapine
  18. Letter to the Editor
  19. Escitalopram in disorder of laughter and crying with predominant laughter incontinence
Heruntergeladen am 25.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2016-0088/html
Button zum nach oben scrollen